Kumar Budur - 01 May 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: HRMY
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:14:12 UTC
Prior SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Kumar Budur filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 18 May 2026.

Key facts

This page summarizes Kumar Budur's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 May 2026, 16:14.

Change

Previous filing in this sequence was filed on 26 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002009762 Primary reporting owner

Budur Kumar

Relationship: CHIEF MEDICAL OFFICER
Address: 630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Signature date: 18 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRMY transaction

Common Stock

Options Exercise

Transaction value
Shares: +18,750
Change %: +132%
Price: $0.000000^*
Shares after: 32,997
Date: 01 May 2026
Ownership: Direct
Footnotes: F1

HRMY transaction

Common Stock

Tax liability

Transaction value
Shares: -8,882
Change %: -27%
Price: $31.83^*
Shares after: 24,115
Date: 01 May 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -18,750
Change %: -33%
Price: $0.000000^*
Shares after: 37,500
Date: 01 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,750
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.

Footnote F2

Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

Footnote F3

The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.